Antibiotic resistance in the community

Medical Journal of Malaysia

Volumn 58, Issue 2, 2003, Pages 156-158

  Lim, V K E ^a  

^a INSTITUTE FOR MEDICAL RESEARCH   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CEFTRIAXONE; CHLORAMPHENICOL; COTRIMOXAZOLE; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; MACROLIDE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL GENE; COMMUNITY; EDITORIAL; GENERAL PRACTITIONER; GEOGRAPHIC DISTRIBUTION; HAEMOPHILUS INFLUENZAE; HEALTH CARE POLICY; HOSPITAL INFECTION; INFECTION; MECA GENE; MEDICAL LITERATURE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NEISSERIA GONORRHOEAE; PENICILLIN RESISTANCE; PREVALENCE; STREPTOCOCCUS PNEUMONIAE; UPPER RESPIRATORY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, BACTERIAL; HUMANS; MALAYSIA;

EID: 0141782615     PISSN: 03005283     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (14)

1. Norazah A, Lim VKE, Munirah SN, Kamel AGM. Staphylococcus aureus carriage in selected communities and their antibiotic susceptibility patterns. Med J Malaysia 2003; 58: 255-61.
2. Lee WS, Puthucheary SD. Species distribution and antibiotic resistance of Shigella isolates in an urban community in Malaysia. Med J Malaysia 2003; 58: 262-67.
3. Teng CL, Nurjahan MI, Hashim NA et al. Upper respiratory tract infections: To what extent is the management evidence based? Med J Malaysia 2003; 58: 159-66.
4. Cizman M, The use and resistance to antibiotics in the community. Int J Antimicrob Agents 2003; 21: 297-307.
5. Ling JM, Lam AW, Chan EW, Cheng AF. What have we learnt from community-acquired infections in Hong Kong? J Antimicrobial Chemother 2003; 51: 895-904.
6. Seppala H, Klankka T, Vuopio-Varluka J et al. The effect of changes in the consumption of macrolide antibiotics and erythromycin resistance in Group A streptococci in Finland. N Engl J Med 1997; 337: 441-6.
7. Hiramatsu K, Okuma K, Ma XX, Yamamoto M, Hori S, Kapi M. New trends in Staphylococcus aureus infections: glycopeptide resistance in hospital and methicillin resistance in the community. Current Opinion in Infectious Diseases 2002; 15: 407-13.
8. Brown EM & Thomas, P. Fusidic acid resistance in Staphylococcus aureus isolates. Lancet 2002; 359: 803.
9. Mason BW, Howard AJ, and Magee JT. Fusidic acid resistance in community isolates of methicillin-susceptible Staphylococcus aureus and fusidic acid prescribing. J Antimicrob Chemother. 2003; 51: 1033-36.
10. Adam D. Global antibiotic resistance in Streptococcus pneumoniae. J Antimicrob Chemother 2002; 50 (Suppl): 1-5.
11. Felmingham D, Feldman C, Hryniewicz W, et al. Surveillance of resistance in bacteria causing community-acquired respiratory tract infections. Clinical Microbiology & Infection 2002; 8 (Suppl 2): 12-42.
12. Rohani MY, Parasakthi N, Raudzah A, and Yasim MY. In-vitro susceptibilities of Streptococcus pneumoniae strains isolated in Malaysia to six antibiotics J. Antimicrob. Chemother. 1999; 44: 852-3.
13. Metlay JP, Shea JA, Crossette LB, Asch DA. Tensions in antibiotic prescribing: pitting social concerns against the interests of individual patients. Journal of General Internal Medicine 2002; 17: 87-94.
14. Bauchner H, Pelton SI, Klein JO. Parents, physicians and antibiotic use. Paediatrics 1999; 103: 395-8.